HICKS KERRY R has filed 4 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 28201 shares of TriSalus Life Sciences, Inc. ($TLSI) on May 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | TriSalus Life Sciences, Inc. | $TLSI | HICKS KERRY R | Director | A | Common Stock | 28201 | $0.00 | 2,317,400.0000 | 49,964,311 | 1.23% | 0.06% |
| May 14, 2026 | TriSalus Life Sciences, Inc. | $TLSI | HICKS KERRY R | Director | A | Director Stock Option (right to buy) | 56403 | $0.00 | 145,625.0000 | 49,964,311 | 63.22% | 0.11% |
| June 12, 2025 | TriSalus Life Sciences, Inc. | $TLSI | HICKS KERRY R | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 89,222.0000 | 32,272,462 | 20.21% | 0.05% |
| Aug. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | HICKS KERRY R | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |